DESIGN THERAPEUTICS INC (DSGN) Stock Cash Flow
USA - NASDAQ:DSGN - US25056L1035 - Common Stock
6.11 USD
+0.1 (+1.58%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.49M | -49.59M | -66.86M | -63.31M | -35.53M | |||
| Depreciation Amortization | 617.00K | 596.00K | 537.00K | 410.00K | 130.00K | |||
| Change In Working Capital | 2.57M | -993.00K | 728.00K | 2.05M | 1.42M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 9.66M | 6.88M | 7.04M | 9.53M | 4.61M | |||
| OPERATING CASH FLOW | -50.34M | -43.10M | -58.56M | -51.32M | -29.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -139.00K | -340.00K | -256.00K | -920.00K | -1.54M | |||
| Other Investing Activity | 24.44M | 44.30M | 52.79M | -220.07M | -52.11M | |||
| INVESTING CASH FLOW | 23.94M | 43.95M | 52.54M | -220.99M | -53.64M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 647.00K | 513.00K | 724.00K | 660.00K | 379.21M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -430.00K | N/A | |||
| FINANCING CASH FLOW | 647.00K | 513.00K | 724.00K | 240.00K | 379.21M | |||
| CHANGE IN CASH | -25.75M | 1.36M | -5.30M | -272.07M | 296.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -50.34M | -43.10M | -58.56M | -51.32M | -29.38M | |||
| Capital Expenditure | -139.00K | -340.00K | -256.00K | -920.00K | -1.54M | |||
| FREE CASH FLOW | -50.47M | -43.45M | -58.82M | -52.24M | -30.92M | |||
All data in USD